These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11166778)
1. Plasma fibronectin levels in ischemic heart disease. Song KS; Kim HK; Shim W; Jee SH Atherosclerosis; 2001 Feb; 154(2):449-53. PubMed ID: 11166778 [TBL] [Abstract][Full Text] [Related]
2. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Orem C; Durmuş I; Kilinç K; Baykan M; Gökçe M; Orem A; Topbaş M Coron Artery Dis; 2003 May; 14(3):219-24. PubMed ID: 12702925 [TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein (a) and ischemic heart disease in patients with hypertensive disease]. Britareva VV; Afanas'eva OI; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA; Pokrovskiĭ SN Kardiologiia; 2002; 42(5):4-8. PubMed ID: 12494139 [TBL] [Abstract][Full Text] [Related]
4. Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling. Ziffels B; Ospel J; Grün K; Neri D; Pfeil A; Fritzenwanger M; Figulla HR; Jung C; Berndt A; Franz M Dis Markers; 2016; 2016():3695454. PubMed ID: 27635109 [TBL] [Abstract][Full Text] [Related]
5. Triglycerides predict plasma fibronectin in children with type I diabetes mellitus rather than diabetes. Erbağci AB; Tarakçioğlu M; Erbağci A; Gözübüyük M; Yilmaz N; Deveci R; Kocabaş R Acta Medica (Hradec Kralove); 2002; 45(1):33-7. PubMed ID: 12143110 [TBL] [Abstract][Full Text] [Related]
6. Hyperinsulinemia as an independent risk factor for ischemic heart disease. Després JP; Lamarche B; Mauriège P; Cantin B; Dagenais GR; Moorjani S; Lupien PJ N Engl J Med; 1996 Apr; 334(15):952-7. PubMed ID: 8596596 [TBL] [Abstract][Full Text] [Related]
7. [Apolipoprotein B100 as a risk factor of acute coronary syndrome and this risk factor effect on arterial hypertension in patients with ischemic heart disease]. Arabidze GG; Pokrovskiĭ SN; Afanas'eva MI; Tebloev KI; Memetov KA; Skriabina EO Ter Arkh; 2005; 77(9):35-9. PubMed ID: 16281487 [TBL] [Abstract][Full Text] [Related]
8. Analysis of factors that affect short-term blood pressure variability in patients with chronic renal failure. Sakai M; Tamura K; Tanaka Y; Tsurumi Y; Okano Y; Koide Y; Endoh T; Matsushita K; Kihara M; Hirawa N; Toya Y; Tokita Y; Ohnishi T; Umemura S Clin Exp Hypertens; 2005; 27(2-3):139-47. PubMed ID: 15835376 [TBL] [Abstract][Full Text] [Related]
9. Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular Risk. Bertsch RA; Merchant MA Perm J; 2015; 19(4):4-10. PubMed ID: 26517432 [TBL] [Abstract][Full Text] [Related]
10. [The cholesterol level in the peripheral blood lymphocytes: the interrelationship with ischemic heart disease in patients with different types of hyperlipidemia]. Bolkhova LA; Fuki IV; Solov'eva EIu; Koshechkin VA; Repin VS Biull Eksp Biol Med; 1993 Nov; 116(11):476-9. PubMed ID: 8312533 [TBL] [Abstract][Full Text] [Related]
11. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups. Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study). Lamarche B; Després JP; Moorjani S; Cantin B; Dagenais GR; Lupien PJ Am J Cardiol; 1995 Jun; 75(17):1189-95. PubMed ID: 7778537 [TBL] [Abstract][Full Text] [Related]
13. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092 [TBL] [Abstract][Full Text] [Related]
14. Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error. Egger M; Smith GD; Pfluger D; Altpeter E; Elwood PC Atherosclerosis; 1999 Apr; 143(2):275-84. PubMed ID: 10217356 [TBL] [Abstract][Full Text] [Related]
15. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Castelli WP; Anderson K Am J Med; 1986 Feb; 80(2A):23-32. PubMed ID: 3946458 [TBL] [Abstract][Full Text] [Related]
16. Plasma fibronectin level and its relationships with lipids, lipoproteins and C-reactive protein in patients with dyslipidaemia during lipid-lowering therapy. Orem C; Orem A; Calapoğlu M; Baykan M; Uydu HA; Erdöl C Acta Cardiol; 2002 Dec; 57(6):421-5. PubMed ID: 12542120 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto. Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034 [TBL] [Abstract][Full Text] [Related]
18. Association study between fibronectin and coronary heart disease. Zhang Y; Zhou X; Krepinsky JC; Wang C; Segbo J; Zheng F Clin Chem Lab Med; 2006; 44(1):37-42. PubMed ID: 16375583 [TBL] [Abstract][Full Text] [Related]
19. Thyroid dysfunction and ischemic heart disease--clinical correlations, progressive implications and impact on the prognosis. Tănase DM; Ionescu SD; Ouatu A; Ambăruş V; Rezuş C; Arsenescu-Georgescu C Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):63-70. PubMed ID: 24741777 [TBL] [Abstract][Full Text] [Related]
20. Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine. Lee DD; Rigonan K; Dequattro V J Am Coll Cardiol; 1993 Nov; 22(5):1438-45. PubMed ID: 8227803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]